Updated:
TEEC Angel Fund
Eugene Zhang's TEEC Angel Fund bridges Silicon Valley seed-stage technology and Chinese strategic capital via the Tsinghua alumni network.
TEEC Angel Fund
TEEC Angel Fund was formed in 2010 by a group of Tsinghua University alumni in Silicon Valley, led by Eugene Zhang and Jinlin Wang. The firm grew out of TEEC (Tsinghua Entrepreneur and Executive Club), the Bay Area chapter of the university's global entrepreneur network founded in 2001. The fund capitalizes on the deep technical bench of Chinese-born, US-educated engineers and operators who cycle through Tsinghua's diaspora — one of the densest concentrations of PhD-level founders in Northern California. The fund invests nearly exclusively at seed stage, with check sizes typically between $100,000 and $500,000 (per Pitchbook, 2022). Its portfolio spans enterprise software, AI/ML, digital health, hardware, and advanced mobility. Confirmed positions include Ginkgo Bioworks, the synthetic biology company that went public via SPAC in 2021, and Cista, a Chinese CMOS image sensor firm that reached unicorn valuation. The fund operates a dual-continent sourcing model: US-based GPs identify companies at formation in California, while limited partners and co-investors based in Beijing provide late-stage follow-on capital and China market entry support. Six portfolio companies have achieved valuations above $1 billion as of 2023. TEEC Angel Fund runs a lean operation from Santa Clara with an additional office in Beijing. The firm does not publish team size, but early partners included Tsinghua-affiliated executives with operating experience at Cisco, Juniper Networks, and early-stage Chinese internet companies. In November 2022, the firm's fourth fund closed above target, though the exact figure remained undisclosed outside limited partner communications. The general partners also maintain close ties to Tsinghua Holdings, the university's investment arm, which occasionally co-invests alongside the fund. Structurally, TEEC Angel Fund functions as a bilateral venture pipeline: it is one of the few pre-Series A investors in the US with the operational ability to directly connect portfolio companies to Chinese corporate acquirers, state-backed industrial funds, and Asian public-market listing venues. While many US firms have retreated from China exposure since 2020, TEEC's limited partner base and partner network remain substantially cross-border, preserving a differentiation that few other seed-stage managers can replicate.
General information
Firm type
Venture Capital
Year founded
2010
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Santa Clara
Corporate office
Santa Clara, CA, United States
Additional offices
Beijing, China
Principals
Eugene Zhang
Founding Partner
Jinlin Wang
Founding Partner
Sector focus
Frequently asked questions
Who makes investment decisions at TEEC Angel Fund?
Eugene Zhang and Jinlin Wang serve as founding partners and the primary decision-makers. The partnership often includes other founding members of the Tsinghua Entrepreneur and Executive Club. Investment committee composition is not publicly documented in detail.
Is TEEC Angel Fund a family office or a traditional venture firm?
It operates as a traditional venture capital firm structured around a closed LP base drawn heavily from the Tsinghua diaspora. The fund is not a single-family office or a multi-family office. Capital comes from alumni entrepreneurs and affiliated corporate entities rather than a single family balance sheet.
Does the fund invest only in companies with Tsinghua-affiliated founders?
Tsinghua affiliation is common but not a formal requirement. The network provides proprietary deal flow, but the fund has backed teams without direct university ties when the technical thesis and US-China bridge angle are strong. Portfolio company Ginkgo Bioworks, for example, was founded by MIT synthetic biologists.
How does TEEC Angel Fund source its deals?
Sourcing flows predominantly through the Tsinghua alumni network in Silicon Valley, which includes engineers, founders, and executives at major technology companies. The Beijing office supplements this by identifying companies seeking China market entry or Asia-based strategic investors. The fund rarely competes in open auction processes, instead securing allocations through warm introductions from network members.
What happens to portfolio companies after seed stage?
TEEC Angel Fund does not reserve significant capital for follow-on rounds. Instead, it uses its Beijing network to introduce later-stage investors — often Chinese strategic funds, corporate venture arms, or US VCs seeking Asia syndicate partners. This handoff model means TEEC's ownership typically dilutes after Series A unless the general partners choose to raise special-purpose vehicles for individual breakout companies.
How has US-China tension affected the fund's operations?
The fund has not publicly detailed internal adjustments since 2020. Public record indicates some LP and co-investor relationships remain cross-border, but the firm has not faced public disclosure of CFIUS-related portfolio disruptions. The structural challenge is inherent: its differentiation relies on bilateral flows that heightened regulatory scrutiny makes harder to maintain.
What is TEEC Angel Fund's track record on exits?
The fund's most prominent liquidity event was the 2021 public listing of Ginkgo Bioworks via a SPAC merger (per Reuters, 2021). Cista achieved unicorn status in China, though exit details remain private. Beyond these, the majority of exits have occurred through M&A transactions where terms were not publicly reported.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: